Therapeutic Solutions International Inc (TSOI)

[centsability4me]

TSOI News History


NEWS : 12/31/18
http://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/78967967/therapeutic-solutions-international-ceo-issues-sha

Therapeutic Solutions International CEO Issues Shareholder Letter


NEWS : 12/10/18
https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/78853508/therapeutic-solutions-international-signs-agreemen

Therapeutic Solutions International Signs Agreement for Licensing JadiCell's Universal Donor Adult Stem Cell Product

NEWS : 12/6/18
http://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/78834511/therapeutic-solutions-international-expands-chroni

Therapeutic Solutions International Expands Chronic Traumatic Encephalopathy Intellectual Property Portfolio
New Data Demonstrates Ability of Immune System to Alter Football Related Brain Injuries


NEWS : 10/25/18
http://ih.advfn.com/p.php?pid=nmona&article=78538984

Therapeutic Solutions International Announces CTE Optimized NeuroStilbene Formulation

NEWS : 9/25/18
https://ih.advfn.com/p.php?pid=nmona&article=78326088

Therapeutic Solutions International Files Patent on Clinical Data Demonstrating Reduction of Inflammatory Cytokines Using NanoStilbeneTM

NEWS : 9/19/2018
https://ih.advfn.com/p.php?pid=nmona&article=78289796

Therapeutic Solutions International Collaborates with Internationally Renowned Neurologist and NFL Charger Hall of Famer to Develop New Intellectual Property for Treatment of Chronic Traumatic Encephalopathy
Company Files Patent and Generates Proof of Concept Data using NeuroStilbene for Prevention of Football Associated Brain Damage

NEWS : 9/4/18
https://ih.advfn.com/p.php?pid=nmona&article=78186786

Therapeutic Solutions International Completes Phase 1 Clinical Trial in Advanced Cancer Patients for Right to Try Access
of its StemVacs Product for American Cancer Patients

NEWS : 8/22/18
https://ih.advfn.com/p.php?pid=nmona&article=78119448

Therapeutic Solutions International Recruits NFL Chargers Hall of Famer Wes Chandler to Lead NeuroStilbene for Chronic Traumatic Encephalopathy in Football Players
Company to Advance NeuroStilbene Product for High-Performance Athletes
Susceptible to Head Injuries

NEWS : 8/13/18
https://ih.advfn.com/p.php?pid=nmona&article=78060284

Therapeutic Solutions International Reports Synergistic Enhancement of Ozone Therapy Efficacy in Prostate, Breast and Ovarian Cancer Cells by Pterostilbene
Clinical Stage Cancer Immunotherapy Biotechnology Company Files Patent Expanding Uses of its Pterostilbene Based Product Pipeline

NEWS : 8/6/18
https://ih.advfn.com/p.php?pid=nmona&article=78013140

Therapeutic Solutions International Develops Microemulsion Formulation of
Alpha Lipoic Acid for Intranasal Delivery

Company Expands Product Pipeline in Neurodegenerative Arena

NEWS : 7/23/18
https://ih.advfn.com/p.php?pid=nmona&article=77913150

Therapeutic Solutions International Recruits Internationally Recognized Cancer Immunotherapy Pioneer Dr. Francesco Marincola to Accelerate StemVacs and NanoStilbene Clinical Development
Company Focuses on Non-Toxic Therapies Using Immune System
to Selectively Kill Cancer Cells through Immunotherapy

NEWS : 7/16/18
https://ih.advfn.com/p.php?pid=nmona&article=77868683

Therapeutic Solutions International, Inc., Releases Intranasal Formulation of Pterostilbene for
Rapid Access to Blood-Brain Barrier
Company Expands its Pterostilbene Based Portfolio into Brain Cancers


NEWS : 7/9/18
https://ih.advfn.com/p.php?pid=nmona&article=77825316

Therapeutic Solutions International, Inc., Appoints Juergen Winkler, MD, ABIHM to Scientific Advisory Board
Pioneer of Functional Medicine Teams Up with Clinical Stage Biotechnology Company in Commercialization of Non-Toxic Immunotherapy

NEWS : 7/2/18
https://ih.advfn.com/p.php?pid=nmona&article=77784227

Therapeutic Solutions International Announces Clinical Proof of Concept of Nanoparticle Pterostilbene Formulation: NanoStilbene™
Early Clinical Trial Data Supports Enhanced Biodistribution of NanoStilbene™ Compared to Standard Pterostilbene When Orally Administered

NEWS : 6/25/18
https://ih.advfn.com/p.php?pid=nmona&article=77734511

Therapeutic Solutions International Releases "IsoStilbene" Injectable Formulation of Pterostilbene Under Granted Patent for Augmentation of Immunotherapy and Targeting of Cancer Stem Cells . IsoStilbene to be Included in Pan American Cancer Treatment Center Protocols

NEWS : 6/18/18
https://ih.advfn.com/p.php?pid=nmona&article=77684969

Therapeutic Solutions International Announces the Appointment of
James Veltmeyer, MD as Chief Medical Officer

NEWS : 6/11/18
http://ih.advfn.com/p.php?pid=nmona&article=77635806

Therapeutic Solutions International Expands Adoptive Immunotherapy Portfolio by Incorporation of "Universal Cancer Antigen" into StemVacs Dendritic Cell Platform

BORIS Info:
http://stemvacs.com/?page_id=145

NEWS : 6/6/18
http://ih.advfn.com/p.php?pid=nmona&article=77606645

Therapeutic Solutions International Announces Licensing of Additional Technologies to
Pan American Cancer Treatment Center

Patent Title: Targeting the Tumor Microenvironment through Nutraceutical Based Immunoadjuvants : Cancer Metabolic DeTox
http://www.marketwired.com/press-release/therapeutic-solutions-files-new-patent-on-targeting-tumor-microenvironment-through-nutraceutical-otc-pink-tsoi-2215015.htm
Patent Title: Methods of Re-Activating Dormant Memory Cells with Anticancer Activity : MemoryMune
http://www.marketwired.com/press-release/therapeutic-solutions-files-patent-on-methods-re-activating-dormant-memory-cells-with-otc-pink-tsoi-2220094.htm
Patent Title: Stimulation of Immunity to Tumor Stem Cell Specific Proteins by Peptide Immunization : StemVacs
http://www.marketwired.com/press-release/therapeutic-solutions-international-announces-filing-new-immunotherapy-patent-exclusive-otc-pink-tsoi-2208787.htm
Patent Title:Augmentation of Anti-Tumor Immunity by Mifepristone and Analogues Thereof : LymphoBoost
http://www.marketwired.com/press-release/therapeutic-solutions-files-new-patent-on-augmentation-anti-tumor-immunity-mifepristone-otc-pink-tsoi-2217703.htm
Patent Title: Activated Leukocyte Extract for Repair of Innate Immunity in Cancer Patients : innaMune
http://www.marketwired.com/press-release/therapeutic-solutions-files-patent-on-blood-derived-innate-immune-system-stimulator-otc-pink-tsoi-2216672.htm

Pan Am Cancer Treatment Center
Telephone: [phone]
Diego Rivera #2339 suite 108
Zona Rio, Tijuana B.C. 22010
www.cancerimmunotherapy.mx
[e-mail]
Pan Am Cancer Treatment Center Intoductory video :

NEWS : 5/31/18
http://ih.advfn.com/p.php?pid=nmona&article=77561606

Therapeutic Solutions International to Provide Patients Access to StemVacs Cancer Immunotherapy through Newly Passed Right to Try Law

NEWS : 5/21/18
http://ih.advfn.com/p.php?pid=nmona&article=77477228

Therapeutic Solutions International Releases "DermalStilbene" a Topical Formulation of Pterostilbene

NEWS : 5/15/18
http://ih.advfn.com/p.php?pid=nmona&article=77431704

Therapeutic Solutions International, Inc., to Initiate Clinical Trial of Patented Cancer Immunotherapy Adjuvant Nanostilbene

NEWS : 5/9/18
http://ih.advfn.com/p.php?pid=nmona&article=77382606

Therapeutic Solutions International, Inc., Announces the Appointment of Nassir Azimi, MD, to Science Board
Company to Iniate Investigational Cardiovascular Study with Dr. Azimi and Nanostilbene

NEWS : 5/1/18
http://ih.advfn.com/p.php?pid=nmona&article=77309980

Therapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial with Pan Am Cancer Treatment Center
Company Aims to Leverage Transfer Factor Pulsed Autologous Dendritic Cells on StemVacs Platform with
Patented Augmenter of Cancer Immunotherapy NanoStilbene

Link to Pan Am Cancer Treatment Centers website :
http://cancerimmunotherapy.mx/web/

Link to TSOI Patent covering NanoStilbene :
https://patents.google.com/patent/US9682047B2/en